TVP23B
gene geneOn this page
Also known as CGI-148YDR084C
Summary
TVP23B (trans-golgi network vesicle protein 23 homolog B, HGNC:20399) is a protein-coding gene on chromosome 17p11.2, encoding Golgi apparatus membrane protein TVP23 homolog B (Q9NYZ1).
Predicted to be involved in protein secretion and vesicle-mediated transport. Predicted to be located in membrane. Predicted to be active in Golgi membrane.
Source: NCBI Gene 51030 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 40 total
- MANE Select transcript:
NM_016078
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20399 |
| Approved symbol | TVP23B |
| Name | trans-golgi network vesicle protein 23 homolog B |
| Location | 17p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-148, YDR084C |
| Ensembl gene | ENSG00000171928 |
| Ensembl biotype | protein_coding |
| Entrez | 51030 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 8 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay
ENST00000307767, ENST00000476139, ENST00000482741, ENST00000571018, ENST00000572845, ENST00000574226, ENST00000574294, ENST00000575261, ENST00000581733, ENST00000582288, ENST00000880247, ENST00000880248, ENST00000920914
RefSeq mRNA: 7 — MANE Select: NM_016078
NM_001316919, NM_001316920, NM_001316921, NM_001316922, NM_001316923, NM_001316924, NM_016078
CCDS: CCDS42274, CCDS82084
Canonical transcript exons
ENST00000307767 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002649249 | 18781183 | 18781305 |
| ENSE00003461775 | 18797579 | 18797668 |
| ENSE00003473839 | 18798812 | 18798943 |
| ENSE00003476262 | 18805541 | 18806714 |
| ENSE00003545095 | 18790896 | 18791040 |
| ENSE00003570975 | 18804138 | 18804266 |
| ENSE00003659275 | 18789353 | 18789435 |
Expression profiles
Bgee: expression breadth ubiquitous, 142 present calls, max score 97.85.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.3113 / max 110.5647, expressed in 1510 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 159819 | 2.1266 | 1098 |
| 159820 | 1.1847 | 831 |
Top tissues by expression
142 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| islet of Langerhans | UBERON:0000006 | 97.85 | gold quality |
| calcaneal tendon | UBERON:0003701 | 96.87 | gold quality |
| stromal cell of endometrium | CL:0002255 | 95.38 | gold quality |
| adrenal tissue | UBERON:0018303 | 94.43 | gold quality |
| esophagus mucosa | UBERON:0002469 | 94.41 | gold quality |
| pancreas | UBERON:0001264 | 94.14 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.86 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.75 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.56 | gold quality |
| endometrium | UBERON:0001295 | 93.54 | gold quality |
| body of pancreas | UBERON:0001150 | 93.37 | gold quality |
| rectum | UBERON:0001052 | 93.18 | gold quality |
| adenohypophysis | UBERON:0002196 | 92.77 | gold quality |
| gall bladder | UBERON:0002110 | 92.64 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 92.57 | gold quality |
| minor salivary gland | UBERON:0001830 | 92.50 | gold quality |
| duodenum | UBERON:0002114 | 92.28 | gold quality |
| pituitary gland | UBERON:0000007 | 92.25 | gold quality |
| vagina | UBERON:0000996 | 92.13 | gold quality |
| adrenal gland | UBERON:0002369 | 92.09 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.07 | gold quality |
| left adrenal gland | UBERON:0001234 | 91.93 | gold quality |
| fallopian tube | UBERON:0003889 | 91.86 | gold quality |
| tonsil | UBERON:0002372 | 91.81 | gold quality |
| right adrenal gland | UBERON:0001233 | 91.58 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.42 | gold quality |
| thoracic aorta | UBERON:0001515 | 91.33 | gold quality |
| esophagus | UBERON:0001043 | 91.29 | gold quality |
| ascending aorta | UBERON:0001496 | 91.28 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
93 targeting TVP23B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
Literature-anchored findings (GeneRIF, showing 1)
- The role of FAM18B in regulating retinal microvascular endothelial cell viability, migration, and endothelial tube formation was determined following RNAi-mediated knockdown of FAM18B. (PMID:25221423)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zgc:112148 | ENSDARG00000001804 |
| danio_rerio | tvp23b | ENSDARG00000057060 |
| mus_musculus | Tvp23b | ENSMUSG00000014177 |
| rattus_norvegicus | AABR07006081.1 | ENSRNOG00000016597 |
| rattus_norvegicus | Tvp23b | ENSRNOG00000050649 |
| drosophila_melanogaster | CG5021 | FBGN0035944 |
| caenorhabditis_elegans | WBGENE00016400 |
Paralogs (2): TVP23A (ENSG00000166676), TVP23C (ENSG00000175106)
Protein
Protein identifiers
Golgi apparatus membrane protein TVP23 homolog B — Q9NYZ1 (reviewed: Q9NYZ1)
All UniProt accessions (6): Q9NYZ1, E5RIS5, I3L376, J3KS67, J3QL63, K7ENL4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the TVP23 family.
RefSeq proteins (7): NP_001303848, NP_001303849, NP_001303850, NP_001303851, NP_001303852, NP_001303853, NP_057162* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008564 | TVP23-like | Family |
Pfam: PF05832
UniProt features (9 total): transmembrane region 4, chain 1, region of interest 1, modified residue 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NYZ1-F1 | 80.87 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 1
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 136 (showing top):
MULLIGHAN_NPM1_SIGNATURE_3_UP, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_SECRETION, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, REN_ALVEOLAR_RHABDOMYOSARCOMA_DN, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, LINSLEY_MIR16_TARGETS, DELACROIX_RAR_BOUND_ES, FORTSCHEGGER_PHF8_TARGETS_DN, ERBB2_UP.V1_DN, ALKBH3_TARGET_GENES, ARID5B_TARGET_GENES, CIITA_TARGET_GENES, DIDO1_TARGET_GENES
GO Biological Process (2): protein secretion (GO:0009306), vesicle-mediated transport (GO:0016192)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): Golgi membrane (GO:0000139), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein transport | 1 |
| secretion by cell | 1 |
| establishment of protein localization to extracellular region | 1 |
| protein localization to extracellular region | 1 |
| transport | 1 |
| cellular process | 1 |
| binding | 1 |
| Golgi apparatus | 1 |
| bounding membrane of organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
392 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TVP23B | CDRT15 | Q96T59 | 714 |
| TVP23B | TMEM60 | Q9H2L4 | 687 |
| TVP23B | CDRT4 | Q8N9R6 | 658 |
| TVP23B | TEKT3 | Q9BXF9 | 540 |
| TVP23B | TRIM16L | Q309B1 | 507 |
| TVP23B | TBC1D28 | Q2M2D7 | 506 |
| TVP23B | SMCO2 | A6NFE2 | 448 |
| TVP23B | FBXW10 | Q5XX13 | 447 |
| TVP23B | TMEM87A | Q8NBN3 | 429 |
| TVP23B | FBXW10B | O95170 | 418 |
| TVP23B | PIGW | Q7Z7B1 | 411 |
| TVP23B | TRMT13 | Q9NUP7 | 394 |
| TVP23B | CNIH4 | Q9P003 | 383 |
| TVP23B | HS3ST3B1 | Q9Y662 | 379 |
| TVP23B | MRTFB | Q9ULH7 | 370 |
IntAct
80 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TVP23B | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TVP23B | SHISA5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TVP23B | SLC35C2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYT16 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PBX3 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| YIPF4 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP19 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIPF6 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC35C2 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| REEP4 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM80 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC10A6 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TVP23B | YIPF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC10A1 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14B | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMMDC1 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIPF2 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SCN3B | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ABHD6 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SHISA5 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSD17B11 | TVP23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| WLS | TVP23B | psi-mi:“MI:0915”(physical association) | 0.490 |
BioGRID (48): TVP23B (Proximity Label-MS), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid)
ESM2 similar proteins: A0A8I3S9V6, A0M8U1, A6NH52, E1BWM5, O35089, P13666, P86050, Q00765, Q0VCK9, Q0X0A5, Q1RLU8, Q29S14, Q2PG42, Q3KNM2, Q3ZC24, Q5BJU5, Q5M7T4, Q5R9I4, Q5R9K4, Q5RE33, Q5T4T1, Q5ZJ41, Q5ZJD7, Q6DD32, Q6GM44, Q6NYF1, Q6P360, Q6PI25, Q7TQ48, Q86TD4, Q8C407, Q8L5Y9, Q8MK44, Q8R1Z9, Q91ZQ0, Q940S0, Q96GC9, Q99K70, Q99KU0, Q9BSR8
Diamond homologs: A1CIM7, A1CW41, A2Q9P5, A3LRT4, A4RME3, A5DRE8, A6NH52, A6SFL7, A6ZY50, A7TGB4, A8N1Z1, B0CQN9, B0Y4Q8, B2ALT5, P38962, Q0CSZ7, Q0UV43, Q18449, Q1E9X9, Q29S14, Q2UUK2, Q4WQJ5, Q54LC9, Q5APA2, Q5R9I4, Q6BVH1, Q6C7V5, Q6CTK9, Q6FM91, Q74ZP5, Q7SGB6, Q8IQC1, Q8LEK2, Q96ET8, Q9D8T4, Q9NYZ1, Q9Y7K7, Q86I95, Q8N769
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
960 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:18781269:G:GT | donor_gain | 1.0000 |
| 17:18789350:CAG:C | acceptor_loss | 1.0000 |
| 17:18789351:A:AG | acceptor_gain | 1.0000 |
| 17:18789351:AG:A | acceptor_gain | 1.0000 |
| 17:18789352:G:GG | acceptor_gain | 1.0000 |
| 17:18789352:GG:G | acceptor_gain | 1.0000 |
| 17:18789352:GGAT:G | acceptor_gain | 1.0000 |
| 17:18789352:GGATA:G | acceptor_gain | 1.0000 |
| 17:18789432:TCAG:T | donor_loss | 1.0000 |
| 17:18789433:CAGG:C | donor_loss | 1.0000 |
| 17:18789434:AG:A | donor_loss | 1.0000 |
| 17:18789435:GG:G | donor_loss | 1.0000 |
| 17:18789436:GTAG:G | donor_loss | 1.0000 |
| 17:18789437:T:G | donor_loss | 1.0000 |
| 17:18790886:T:TA | acceptor_gain | 1.0000 |
| 17:18797577:AGAAT:A | acceptor_gain | 1.0000 |
| 17:18797578:GA:G | acceptor_gain | 1.0000 |
| 17:18797578:GAAT:G | acceptor_gain | 1.0000 |
| 17:18797578:GAATG:G | acceptor_gain | 1.0000 |
| 17:18797665:AAAGG:A | donor_loss | 1.0000 |
| 17:18797666:AAGG:A | donor_loss | 1.0000 |
| 17:18797667:AG:A | donor_loss | 1.0000 |
| 17:18797668:GGTAA:G | donor_loss | 1.0000 |
| 17:18797669:G:GA | donor_loss | 1.0000 |
| 17:18797670:T:A | donor_loss | 1.0000 |
| 17:18798806:TTATA:T | acceptor_loss | 1.0000 |
| 17:18798807:TATA:T | acceptor_loss | 1.0000 |
| 17:18798809:TA:T | acceptor_loss | 1.0000 |
| 17:18798810:A:G | acceptor_loss | 1.0000 |
| 17:18798811:GGA:G | acceptor_gain | 1.0000 |
AlphaMissense
1355 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:18791040:G:C | K80N | 0.989 |
| 17:18791040:G:T | K80N | 0.989 |
| 17:18798860:T:C | F127L | 0.986 |
| 17:18798862:T:A | F127L | 0.986 |
| 17:18798862:T:G | F127L | 0.986 |
| 17:18797612:T:A | W92R | 0.984 |
| 17:18797612:T:C | W92R | 0.984 |
| 17:18797654:T:C | F106L | 0.981 |
| 17:18797656:T:A | F106L | 0.981 |
| 17:18797656:T:G | F106L | 0.981 |
| 17:18791026:T:C | F76L | 0.979 |
| 17:18791028:T:A | F76L | 0.979 |
| 17:18791028:T:G | F76L | 0.979 |
| 17:18791024:A:T | D75V | 0.972 |
| 17:18797581:T:A | N81K | 0.972 |
| 17:18797581:T:G | N81K | 0.972 |
| 17:18798893:T:A | W138R | 0.972 |
| 17:18798893:T:C | W138R | 0.972 |
| 17:18790936:A:C | S46R | 0.970 |
| 17:18790938:T:A | S46R | 0.970 |
| 17:18790938:T:G | S46R | 0.970 |
| 17:18791024:A:C | D75A | 0.969 |
| 17:18797589:G:A | G84D | 0.963 |
| 17:18804153:G:C | G160R | 0.962 |
| 17:18791020:T:C | C74R | 0.960 |
| 17:18791039:A:T | K80M | 0.959 |
| 17:18791025:C:A | D75E | 0.958 |
| 17:18791025:C:G | D75E | 0.958 |
| 17:18797607:T:C | L90P | 0.958 |
| 17:18797614:G:C | W92C | 0.958 |
dbSNP variants (sampled 300 via entrez): RS1000226487 (17:18801334 G>T), RS1000587913 (17:18788288 G>A), RS1000618941 (17:18788054 T>A,C), RS1000768770 (17:18794287 T>C), RS1001138923 (17:18794720 T>A), RS1001404611 (17:18782485 A>G), RS1001416826 (17:18788944 A>G), RS1001429076 (17:18789149 TC>T), RS1001487527 (17:18781973 G>T), RS1001767274 (17:18782947 A>G), RS1001941231 (17:18793998 AAG>A), RS1001972427 (17:18793756 T>C,G), RS1002323452 (17:18781406 C>T), RS1002354226 (17:18781213 C>G), RS1002465670 (17:18806145 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation, decreases expression, increases expression | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Cadmium Chloride | increases abundance, increases expression | 2 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| alpha-pinene | affects cotreatment, increases oxidation, increases abundance | 1 |
| hydroxyhydroquinone | increases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acrolein | affects cotreatment, increases oxidation, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Oxygen | decreases expression | 1 |
| Ozone | affects cotreatment, increases oxidation, increases abundance | 1 |
| Thiram | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Asbestos, Crocidolite | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Volatile Organic Compounds | affects cotreatment, increases oxidation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.